
8-Isoquinolinol | CAS:3482-14-2
8-Isoquinolinol
- 名称:8-羟基异喹啉 | 8-Isoquinolinol
- CAS号:3482-14-2
- 别名:8-Hydroxyisoquinoline; 2H-isoquinolin-8-one
- 分子式:C9H7NO
- 分子量:145.16
- EINESC号:
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors.G D Hartman et al.Bioorganic & medicinal chemistry letters, 9(6), 863-868 (1999-04-17)
Metabolism of CJ-036878, N-(3-phenethoxybenzyl)-4-hydroxybenzamide, in liver microsomes and recombinant cytochrome P450 enzymes: metabolite identification by LC-UV/MS(n) and (1)H-NMR.H Nishida et al.Xenobiotica; the fate of foreign compounds in biological systems, 37(12), 1394-1407 (2007-11-23)
Influence of Secondary Interactions on the Structure, Sublimation Thermodynamics, and Solubility of Salicylate:4-Hydroxybenzamide Cocrystals. Combined Experimental and Theoretical Study.Alex N Manin et al.The journal of physical chemistry. B, 119(33), 10466-10477 (2015-08-11)
Structure-based design of achiral, nonpeptidic hydroxybenzamide as a novel P2/P2' replacement for the symmetry-based HIV protease inhibitors.R S Randad et al.Bioorganic & medicinal chemistry, 4(9), 1471-1480 (1996-09-01)
Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.Alex N Manin et al.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 65, 56-64 (2014-09-15)
CYP3A4 and CYP3A5 catalyse the conversion of the N-methyl-D-aspartate (NMDA) antagonist CJ-036878 to two novel dimers.C Emoto et al.Xenobiotica; the fate of foreign compounds in biological systems, 37(12), 1408-1420 (2007-10-19)
Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.Y S Lai et al.Journal of medicinal chemistry, 40(2), 226-235 (1997-01-17)
A novel complex of a phenolic derivative with insulin: structural features related to the T-->R transition.G D Smith et al.Protein science : a publication of the Protein Society, 5(8), 1502-1511 (1996-08-01)
Energetics of the O-H bond and of intramolecular hydrogen bonding in HOC6H4C(O)Y (Y = H, CH3, CH2CH=CH2, C[triple bond]CH, CH2F, NH2, NHCH3, NO2, OH, OCH3, OCN, CN, F, Cl, SH, and SCH3) compounds.Carlos E S Bernardes et al.The journal of physical chemistry. A, 112(40), 10029-10039 (2008-09-13)
Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives.Yuya Ohtsuki et al.Biochemical and biophysical research communications, 509(1), 287-293 (2018-12-28)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!